Skip to main content

Gary Lyons

Equibles does not estimate personal net worth.

Get an email with a short summary when Travere Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get TVTX alerts

About Gary Lyons

Gary Lyons is recorded as Board Member at Travere Therapeutics, Inc. (TVTX) since January 1, 2014. The newest filing on record that lists Gary Lyons as Board Member at Travere Therapeutics, Inc. (TVTX) is dated April 6, 2026. Travere Therapeutics, Inc. reported in an 8-K filed May 16, 2025 a re-election or new board role (Director) for Gary Lyons, on the board since at least 2014, effective May 15, 2025. Travere Therapeutics, Inc. reported in an 8-K filed May 13, 2024 a re-election or new board role (Director) for Gary Lyons, on the board since at least 2014, effective May 8, 2024. Travere Therapeutics, Inc. reported in an 8-K filed May 22, 2023 a re-election or new board role (Director) for Gary Lyons, on the board since at least 2014, effective May 17, 2023. Travere Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Travere Therapeutics, Inc. includes Bradley Campbell (CEO and Board Member), Bradley L. Campbell (CEO and Board Member), Christopher Cline (CFO) and 7 others.

“The Company's stockholders elected the ten persons listed below to serve until the Company's 2026 Annual Meeting of Stockholders.”
Travere Therapeutics, Inc. Form 8-K, filed May 16, 2025 · Read the filing
“The Company’s stockholders elected the ten persons listed below to serve until the Company’s 2025 Annual Meeting of Stockholders.”
Travere Therapeutics, Inc. Form 8-K, filed May 13, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Travere Therapeutics, Inc.

Recent activity